TNFSF11 and postmenopausal osteoporosis: Additionally, tissue necrosis factors α (TNF-α) was found to promote osteoblast apoptosis and indirectly stimulate osteoclastogenesis via B cell-produced receptor-activator of NF-κB ligand (RANKL), leading to bone loss during postmenopausal osteoporosis (63, 64).